Merck's RSV antibody Clesrovimab for infants shows 60.4% effectiveness in mid-to-late stage clinical trial MD Bureau19 Oct 2024 12:15 PM ISTThe drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
Block Novo Holdings' USD16.5B Catalent acquisition: Consumer Groups Urge FTC over antitrust concerns MD Bureau19 Oct 2024 11:30 AM ISTThe deal could constrain options for competitors such as Amgen, Pfizer, Roche, and AstraZeneca , who are reportedly developing their own GLP 1 drugs.
Medical Bulletin 07/ October/ 2024 Dr. Bhumika Maikhuri7 Oct 2024 3:00 PM ISTHere are the top medical news for the day:Want to Prevent Back Pain? Reduce Sitting TimeA new study from the University of Turku in Finland showed...
WHO recommends maternal vaccine and antibody shot for preventing RSV in infants Dr. Bhumika Maikhuri7 Oct 2024 8:45 AM ISTThe World Health Organization recommended vaccinating pregnant women and administering infants with an antibody to prevent severe respiratory synctial...
Astrazeneca Calquence granted priority review by USFDA for previously untreated mantle cell lymphoma Ruchika Sharma5 Oct 2024 2:30 PM ISTCambridge: AstraZeneca's supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted and granted Priority Review in...
USFDA grants priority review to AstraZeneca-Daiichi Sankyo Enhertu for HER2-low, HER2 Ultralow Breast Cancer Ruchika Sharma3 Oct 2024 9:15 AM ISTAstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and...
AstraZeneca FluMist gets USFDA nod for self-administered influenza vaccine Ruchika Sharma21 Sept 2024 12:24 PM ISTAstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a needle-free nasal spray, was...
FDA approves Benralizumab for eosinophilic granulomatosis with polyangiitis Dr. Kamal Kant Kohli20 Sept 2024 9:45 AM ISTAstraZeneca's Fasenra (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with...
AstraZeneca Fasenra approved in China for severe eosinophilic asthma Ruchika Sharma23 Aug 2024 4:05 PM ISTCambridge: AstraZeneca's Fasenra (benralizumab) has been approved in China by the country's National Medical Products Association (NMPA) for the...
Daiichi Sankyo, AstraZeneca Enhertu gets USFDA breakthrough therapy designation for certain patients with HER2 low or HER2 ultralow metastatic breast cancer Ruchika Sharma21 Aug 2024 3:37 PM ISTTokyo: ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of unresectable...
CDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab Dr. Divya Colin19 Aug 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
AstraZeneca gets USD 107 million Pfizer verdict overturned in US cancer drug patent fight Ruchika Sharma19 Aug 2024 4:45 PM ISTCambridge: AstraZeneca has convinced a Delaware federal judge to throw out a jury's decision that the company owes USD 107.5 million for...
